News

The GPCR Drug Discovery Research Group of GRIB has done a study focused on a specific cellular receptor, the cannabinoid receptor type 2 (CB2), a...

Xoel Mato Blanco, member of the neurogenomics group led by Gabriel Santpere, has published his first paper on Nature Magazine...

Lilian Boll has defended her thesis on July 8 at 10h, in room 61.210 of campus Mar Barcelona. ...

We have reached the end of the PRBB Computational Genomics course ...

José Manuel Ruiz and Paula Mayo González, members of the neurogenomics group, attended the 11th European Conference of Comparative Neurobiology (ECCN2025) meeting in San Juan,...

Lilian Marie Boll and Marta Espinosa Camarena presented their work at the congress of the European Association for Cancer Research (EACR)...

Cell membrane proteins hide secret gateways that can be used to modify cell behavior. This has been demonstrated in a study led by the Hospital del...

Researchers identify predictive markers of response to immunotherapy treatment in a study involving data from over 700 patients across six different cohorts, published in Nature...

David Aranda, a neurodivergent researcher on GRIB'S Group, talks to us about how his structured way of thinking has become key asset to advance...